Xenon Pharmaceuticals Inc.·4

Mar 24, 7:18 PM ET

KENNEY CHRISTOPHER JOHN 4

4 · Xenon Pharmaceuticals Inc. · Filed Mar 24, 2023

Insider Transaction Report

Form 4
Period: 2023-03-24
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
Transactions
  • Sale

    Common Shares

    2023-03-24$35.01/sh700$24,5070 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION